Baxa and SINOPHARM sign distribution agreement

Baxa Corporation, a US-based medical device company in Englewood, Colorado, has signed an exclusive four-year distribution agreement with SINOPHARM, a China National Pharmaceutical Foreign Trade Corporation, to promote sales of its products in China.

While the agreement covers all Baxa products, the ExactaMix(TM) 2400 Automated Compounder and the Repeater(TM) Pharmacy Pump have been recognized as ones that will increase efficiency for the hospitals targeted by Baxa and SINOPHARM in the People's Republic of China (PRC). Due to their existing practice of manual preparation, the companies expect that more than 250 hospitals could benefit from the Baxa pharmacy automation equipment.

The partners anticipate that Baxa Corporation's expertise in automation could greatly improve the existing processes in Chinese hospitals - making their pharmacy operations more accurate, safe and efficient. "Baxa products are used all across the world every day by thousands of pharmacies. By entering the Chinese market, patients there will access the same outstanding quality that Baxa products have provided for 35 years in other parts of the world," states Phil Walsh, Baxa Director of International Sales.

"In China, the curtain has just been raised on the automation and digitization of the hospital pharmacy. Baxa products serve as an integral part for pharmacy automation," states Li Hai Bo, Medical Equipment Manager, SINOPHARM. "Parenteral nutrition is widely used in China," he continues, "however SINOPHARM believes that the current practice of manual preparation is inadequate and may not meet the varied needs of individual patients."

A key component of this partnership is the recent announcement of the China State Council to allocate 850 billion Yuan ($123 billion USD) to reform its medical and healthcare system. Technological advancement was cited as being vital to the plan's success in improving the quality of medical services to the country's 1.3 billion people.